Skip to content
PeptideWiki.bio

Cognitive

Cortexin

InjectableEvidence BEvery day
Half-life
variesby component
Typical vial
5 / 10mg
Research amounts
5–10mg

per administration

Common schedule
Every day
Some human use

It has been used in people, but no trial has settled how much or how often.

Licensed as a medicine in Russia.

Quick start

Cortexin at a glance — the figures, plus how it's commonly run. Reference only, not medical advice.

Typical dose
5–10 mg per administration
How often
Every day
Where
Commonly subcutaneous Sites and rotation
Storage
Dry vial kept cold and dark; a mixed vial in the fridge at 2–8 °C. Details

A research and community reference, not medical advice. Figures are descriptive, vary between sources, and are not a recommendation for use.

Work out your draw

These numbers are a starting point — change any of them.

Vial label

Copy this into your label printer.

Published research contexts for Cortexin describe 510 mg per administration. Descriptive only, not a recommendation.

Like Cerebrolysin, a mixture of low-molecular-weight cortical polypeptides rather than a single molecule, so no single elimination half-life describes it and none is modelled.

Licensed as a medicine in Russia, where the lyophilised powder is reconstituted and given as an intramuscular injection. Like Cerebrolysin it is a mixture of low-molecular-weight cortical polypeptides rather than a single molecule, and no Western dose-ranging trial fixes a schedule, so no schedule table is shown.

Where these numbers come from

  • Russian Cortexin neuropeptide literatureA bovine/porcine cortical polypeptide fraction; most evidence is Russian-language clinical and preclinical work, with no Western dose-ranging trial.

Next steps